Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Efficacy and Safety of Methoxyflurane Vaporized (PENTHROX) in the Treatment of Acute Trauma Pain in Pre-hospital Setting and in the Emergency Department in Italy: a Multicentre, Randomized, Controlled, Open-label Study

Trial Profile

Efficacy and Safety of Methoxyflurane Vaporized (PENTHROX) in the Treatment of Acute Trauma Pain in Pre-hospital Setting and in the Emergency Department in Italy: a Multicentre, Randomized, Controlled, Open-label Study

Recruiting
Phase of Trial: Phase III

Latest Information Update: 15 Dec 2018

At a glance

  • Drugs Methoxyflurane (Primary) ; Ketoprofen; Morphine; Paracetamol
  • Indications Acute pain
  • Focus Therapeutic Use
  • Acronyms MEDITA
  • Sponsors Mundipharma Pharmaceuticals srl
  • Most Recent Events

    • 22 Nov 2018 Trial design published in the Advances in Therapy.
    • 01 Aug 2018 Planned End Date changed from 1 Jul 2018 to 1 Dec 2018.
    • 01 Aug 2018 Planned primary completion date changed from 1 Jul 2018 to 1 Dec 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top